Sphera Funds Management Ltd. Intellia Therapeutics, Inc. Transaction History
Sphera Funds Management Ltd.
- $545 Million
- Q3 2024
A detailed history of Sphera Funds Management Ltd. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 291,080 shares of NTLA stock, worth $3.32 Million. This represents 1.1% of its overall portfolio holdings.
Number of Shares
291,080
Previous 139,419
108.78%
Holding current value
$3.32 Million
Previous $3.12 Million
91.7%
% of portfolio
1.1%
Previous 0.46%
Shares
7 transactions
Others Institutions Holding NTLA
# of Institutions
314Shares Held
91.5MCall Options Held
442KPut Options Held
880K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.3MShares$140 Million2.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.63MShares$110 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$110 Million0.0% of portfolio
-
State Street Corp Boston, MA5.14MShares$58.7 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.95MShares$56.5 Million3.75% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $867M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...